Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study

BACKGROUND: Progressive Supranuclear Palsy (PSP) is a sporadic and progressive neurodegenerative disease which belongs to the family of tauopathies and involves both cortical and subcortical structures. No effective therapy is to date available. METHODS/DESIGN: Autologous bone marrow (BM) mesenchyma...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Rosaria, Canesi, Margherita, Isalberti, Maurizio, Isaias, Ioannis Ugo, Montemurro, Tiziana, Viganò, Mariele, Montelatici, Elisa, Boldrin, Valentina, Benti, Riccardo, Cortelezzi, Agostino, Fracchiolla, Nicola, Lazzari, Lorenza, Pezzoli, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912501/
https://www.ncbi.nlm.nih.gov/pubmed/24438512
http://dx.doi.org/10.1186/1479-5876-12-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912501/
https://www.ncbi.nlm.nih.gov/pubmed/24438512
http://dx.doi.org/10.1186/1479-5876-12-14

Ejemplares similares